Association between metabolic dysfunction-associated fatty liver disease and cardiovascular autonomic neuropathy in type 2 diabetes
MAFLD is independently associated with a higher prevalence of DCAN in patients with T2DM. The risk was further amplified when high FIB-4 index (FIB-4 >1.3) was present among those with MAFLD. Hence, screening for MAFLD and its associated high FIB-4 levels may help identify patients with T2DM at a higher risk of DCAN.
Authors
- Rong Peng
- S. Zhang
- Juan Liu (ORCID: https://orcid.org/0000-0002-9108-2026)
- FU Xiaoying
- Yaoyun Ao
- Zeshan Huang
- Enni Cen
- Jian Kuang
- Junnian Chen
Institutions
- Medical Center Hospital (US)
- Guangdong Academy of Medical Sciences (CN)
- Jiangmen Central Hospital (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2026-01-28
- DOI
- https://doi.org/10.3389/fendo.2025.1711660
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China